The De La Cruz acne treatment, which is available on Amazon, is a 10-minute wash-off mask that targets a variety of acne ...

The drawbacks of retinoids involve the potential for irritancy, which can be concentration- and vehicle-dependent.

Emrosi approved by FDA on November 4 for the treatment of inflammatory lesions of rosacea in adults Cosibelimab PDUFA goal date of December 28 for potential approval to treat metastatic or locally adv ...

Emrosi approved by FDA on November 4 for the treatment of inflammatory lesions of rosacea in adultsCosibelimab PDUFA goal date of December 28 for ...

Complete enrollment in its DMT310 Phase 3 STAR-1 clinical trial in moderate-to-severe acne. Dermata expects to complete enrollment in the STAR-1 study by the end of 2024 and plans to announce topline ...

Continuing to advance the pipeline and remain on-track to engage with the FDA on TP-04 (Papulopustular Rosacea) and TP-05 ...

The U.S. Food and Drug Administration has approved Journey Medical's Emrosi (minocycline hydrochloride) for the treatment of ...

Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), whose mission is to focus on unmet needs and apply proven science and new ...

A doctor has offered guidance on managing a common skin condition that often worsens during the colder months. Sharing advice ...

According to the NHS, rosacea is a long-term skin condition that can cause redness, dry skin, and swelling, and it can be ...

U.S. FDA approved EmrosiTM (Minocycline Hydrochloride Extended Release Capsules, 40 mg) for the <a target=_blank href= ...

The company's FDA-approved drug Sofdra is the first for the common and embarrassing condition of excessive sweating.